Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 8/12/2019
SIETES contiene 92850 citas

 
 
<< anterior 21 a 40 de 627 siguiente >>
Presentar resultados
Seleccionar todas
21. Cita con resumen
Moszynski P. Global Fund suspends support for all new projects until 2014. BMJ 2011;343:1124. [Ref.ID 91914]
22. Cita con resumen
Limb M. Study reveals corporate links of global foundations. BMJ 2011;342:891. [Ref.ID 90478]
23. Cita con resumen
Sridhar D, Gostin LO. Reforming the World Health Organization. JAMA 2011;305:1585-6. [Ref.ID 90414]
24. Cita con resumen
McGirk J. Norway investigates Gaza's drug crisis. Lancet 2011;377:1225-6. [Ref.ID 90367]
25. Cita con resumen
Zarocostas J. NIH puts first antiretroviral patent into worldwide drug pool. BMJ 2010;341:751. [Ref.ID 89523]
26.Tiene citas relacionadas Cita con resumen
Pasqualone F. Bristol-Myers Squibb clarification on didanosine supply. Lancet 2010;376:1054. [Ref.ID 89424]
27. Cita con resumen
Shetty P. Bernard Pécoul: championing the cause of neglected diseases. Lancet 2010;376:677. [Ref.ID 89245]
28.
Santosham M, Chandran A, Fitzwater S, Fischer-Walker C, Baqui AH, Black R. Progress in barriers for the control of diarrhoeal disease. Lancet 2010;376:63-7. [Ref.ID 88858]
29.Tiene citas relacionadas Cita con resumen
Kamal-Yanni M, Nichols K, Tallah E, Otwoma N. Open letter to Lamberto Andreotti, Chief Executive Officer Bristol-Myer Squibb. Lancet 2010;375:2213. [Ref.ID 88825]
30.Tiene citas relacionadas Cita con resumen
Tshefu AK, Gaye O, Kayentao K, Thompson R, Bhatt KM, Sesay SSS, Bustos DG, Tjitra E, Bedu-Addo G, Borghini-Fuhrer I, Duparc S, Shin CS, Fleckenstein L, and the Pyronaridine-artesunate Study Team. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial. Lancet 2010;375:1457-67. [Ref.ID 88419]
31.Tiene citas relacionadas
Nosten FH. Pyronaridine-artesunate for uncomplicated falciparum malaria. Lancet 2010;375:1413-4. [Ref.ID 88412]
32.Tiene citas relacionadas Cita con resumen
Anónimo. Malaria 2010: more ambition and accountability please. Lancet 2010;375:1407. [Ref.ID 88409]
33. Cita con resumen
Wise J. GSK makes details of potential antimalarials freely available. BMJ 2010;340:234. [Ref.ID 87779]
34.Tiene citas relacionadas Cita con resumen
't Hoen E. Pharmaceutical companies and the UNITAID patent pool. Lancet 2010;375:30. [Ref.ID 87530]
35. Cita con resumen
Anónimo. Drug development for neglected diseases: pharma's influence. Lancet 2010;375:2. [Ref.ID 87520]
36. Cita con resumen
Day M. Only 2% of food aid is spent on reducing malnutrition in children. BMJ 2009;339:1164. [Ref.ID 87192]
37. Cita con resumen
Márquez M. Health-workforce development in the Cuban health system. Lancet 2009;374:1574-5. [Ref.ID 86931]
38. Cita con resumen
Sukkar E. The cost of donated drugs. BMJ 2009;339:832-3. [Ref.ID 86918]
39. Cita con resumen
Debens B. DNDi: 100 years of Chagas disease, but R&D lacking. Scrip 2009;3456:25. [Ref.ID 86506]
40.Enlace a cita original
Schopper D, Upshur R, Matthys F, Singh JA, Bandewar SB, Ahmad A, van Dongen E. Research ethics review in humanitarian contexts: the experience of the independent ethics review board of Médicins Sans Frontières. PLOS Medicine 2009;6:115. [Ref.ID 86425]
Seleccionar todas
 
<< anterior 21 a 40 de 627 siguiente >>